Globavend is trading 6.7% down at $0.98 on October 14, with broader market pressure after inflation data a possible backdrop. - Hotter-than-expected September inflation raised rate-hike concerns and pressured U.S. stocks; Reuters reported futures turned lower after the data. This does not establish the direct cause of Globavend’s decline. - Globavend’s announced ThinkEquity presentation is scheduled for October 15, not October 14.